Widgets for Webmasters
BioSante Pharmaceuticals Announces Reacquisition of Elestrin(TM), FDA Approved for Treatment of...
genengnews.com 7 hrs agoNews source: Business Wire BioSante Pharmaceuticals, Inc. announced today that it has reacquired Elestrin (estradiol gel) from Nycomed US who in February 2008 acquired Bradley Pharmaceuticals, Inc., BioSante's previous licensee...

